Pioneer Academics’ Post

In 2023, the total output value of Guangzhou's biomedicine and health care industry will reach 117.8 billion yuan, making it one of the strategic emerging industries focused on development by Guangzhou. In order to gather this industry for efficient development, Guangzhou has created an international biological island, covering an area of about 1.83 square kilometers. It is adjacent to Guangzhou University Town in the south and Pazhou International Convention and Exhibition Center in the north. The main industrial development directions are the creation of new biological drugs, bioenergy, and biotechnology. Research and development in information, genetic engineering, protein engineering, and marine biology currently gathers more than 500 biomedical companies. At the Guangzhou High-Quality Development Conference held in February this year, new energy storage, new energy vehicles, biomedicine, low-altitude economy and other new kinetic energy industries were mentioned many times, highlighting that the authorities attach great importance to biomedicine and will become one of the pillar industries. one. At the same time, the Guangzhou government recently announced support for innovative drug research and development and clinical trials, with the maximum cumulative funding for a single enterprise reaching 100 million yuan. The excellent medical level (67 tertiary hospitals, third in the country) is one of the reasons why Guangzhou attracts people from all over the country to work and live here. Many friends from other places say that Guangzhou is very safe. If you like this post, please share it with more people and explore interesting information together. #china —————————————————————— I am: hanson lee-李则明 A man who once worked in a Sino-Japanese joint venture is now a shareholder of a travel company and the founder of a clothing brand. Share business ideas and unique anecdotes with everyone. Hobbies are running and drinking coffee. Connect with more outstanding friends through LinkedIn to promote communication and grow together.

[Medical Technology] On May 7, the National Health Commission introduced the progress of high-quality development in public hospitals. Efforts have been continuously made to construct a new system, leading new trends, enhancing new efficiency, initiating new driving forces, and fostering a new culture. Among them, Jiangsu Province, as a demonstration city for the reform and high-quality development of existing public hospitals, is promoting the optimization and strengthening of national pilot hospitals. Nanjing Drum Tower Hospital has seized the opportunity as a pilot hospital for high-quality development, strengthened technological innovation, and has seen a significant increase in major projects funded by the Ministry of Science and Technology and the National Natural Science Foundation in the past two years. To promote "Internet + Nursing Services," many provinces across the country have implemented various degrees of "Internet + Nursing Services." Currently, more than 3,000 medical institutions provide over 60 projects in seven categories of medical nursing services, allowing patients to receive corresponding nursing services at home. Source: National Health Commission of the People's Republic of China, as of May 7, 2024. Learn more about the Global X China Biotech ETF (2820) and detailed risk disclosures: https://lnkd.in/dzc47a3 Learn more about the Global X China MedTech ETF (2841) and detailed risk disclosures: https://lnkd.in/gFjKUuwa #China #Medtech #Biotech #Thematic #ETF #GlobalXETFsHongKong #GlobalX - This material is intended for Hong Kong investors only. It is not a solicitation, offer, or recommendation to buy or sell any security or other financial instrument. Investment involves risks. Past performance information presented is not indicative of future performance. Investing in the funds may expose to risks (if applicable) including general investment risk, equity market risk, sector/market concentration risk, active / passive investment management risk, tracking error risk, trading risk, risk in investing financial derivative instruments, securities lending risk, distributions paid out of capital or effectively out of capital risk. Investors should refer to the Fund's prospectus for details, including the risk factors. Issuer: Mirae Asset Global Investments (Hong Kong) Limited. This material has not been reviewed by the Securities and Futures Commission. Copyright © 2024 Mirae Asset Global Investments. All rights reserved. 

Online Symposium Alert! 📣 Let’s delve into the online symposium on Cytotoxicity Effects of Microplastic Particles on Human Intestinal Model. 🔬 📆 Date: 5 March 2024 (Tuesday). ⏰ Time: (MYT) 03:00pm – 04:00pm. 💻 Online Venue: Microsoft Teams. 🔗 Registration Link: https://lnkd.in/gYdGcgcc This research delves into the cytotoxic effects of microplastic particles on a human intestinal model, examining potential harm to the gastrointestinal system. ⚗ 🧑 Microplastic, tiny plastic particles commonly present in the environment, may interact with human cells upon ingestion. 🌱 The study exposes a human intestinal model to microplastics, evaluating their effects on cell viability, function, and potential health consequences over time. 💊 This investigation is essential for assessing the safety implications of human exposure to microplastics. 🛡 Esteemed Invited speaker: Dr. Pornwipa Phuangbubpha Lecturer, Faculty of Science, Silpakorn University Thailand. #360Network #IIU #InternationalCollaboration #GlobalNetwork 

Despite the growth of life sciences in Europe, the gap with the United States and China is increasing significantly. This was a key finding in the ‘Attracting Life Science Investments in Europe report - Fourth Edition, 2023’ - an initiative of the BioMed Alliance, EuropaBio and Johnson & Johnson. The report uses 22 indicators for life science investments to assess 22 countries’ strengths, weaknesses and investment profiles. It found that Europe scores well in education, publications, exports and clinical trials - but there are big gaps in public research, availability of private equity and the transfer of specific knowledge into technology. As a result, the revenue generated from life sciences in Europe is much less than in the US.
The report also found that Europe’s life science and healthcare sector are fragmented and it is not currently taking advantage of its size potential, unlike China. Europe doesn’t benefit from a single market in healthcare and life sciences as they do in the US - it’s much more complicated and slower - so we need to make it more effective and efficient.

 Find out more: https://bit.ly/3Umpgmn Invested in hEUman health #EUInvestsinLife #LifeSciences

What’s fuelling the growth of life sciences deal activity in China? Read our latest article to learn about how government policies have shaped the growth of the sector, and dive into the untapped opportunities making the sector an attractive investment proposition: https://lnkd.in/g477jG8G   #JLL #realestate #lifesciences #China #Shanghai

Date for your diary - 16/10/2024 9.30am - 2.30pm The pandemic threw the life sciences industry into the spotlight, with the UK emerging as a life sciences superpower. In fact, UK life science exports were worth £24.2 billion in 2021. From aging populations to aging equipment and infrastructure, global markets are calling out for innovative technologies to solve their challenges. No more so than the two largest life sciences markets – the US and China. Between them, they accounted for almost $500 billion worth of medical imports in 2022. And your business could be the answer. But how can you break into these high growth markets? Join Santander UK and their eco-system of international providers for an exclusive face-to-face seminar which aims to give you invaluable insights and strategies to effectively navigate and thrive in the two largest healthcare markets in the world. Who is this seminar for? Companies across the life science sector with innovative products and existing or potential ambitions to grow their business internationally, specifically in the US and/or China. This includes: • Advanced medical devices and technologies. • Digital health solutions. • Biotech. • Pharmaceuticals. Join this seminar to: • Discover the market opportunities for your business. • Get tips for navigating the regulatory landscape in both markets. • Explore new partnership opportunities within each market. The seminar is free-of-charge to attend but subject to confirmation from the event organisers due to limited capacity. Registration Link: https://lnkd.in/e54HedBz #seminar #lifescience #china #US

https://lnkd.in/dCfJsNFa Peoples Republic of China is making tremendous progress in every field including Research publications and Clinical Trials. At present maximum number of research papers are being published from United States and China and by the Year 2025, it is expected that China will emerge as the world leader in the field of #research and #clinicaltrials . Other countries which are giving too much importance to clinical trials and are performing these studies apart from USA and China include Japan, South Korea and Brazil while India has also made lot of progress. #china #researchopportunity #researchers #clinicalresearch

Date for your diary - 16/10/2024 9.30am - 2.30pm The pandemic threw the life sciences industry into the spotlight, with the UK emerging as a life sciences superpower. In fact, UK life science exports were worth £24.2 billion in 2021. From aging populations to aging equipment and infrastructure, global markets are calling out for innovative technologies to solve their challenges. No more so than the two largest life sciences markets – the US and China. Between them, they accounted for almost $500 billion worth of medical imports in 2022. And your business could be the answer. But how can you break into these high growth markets? Join Santander UK and their eco-system of international providers for an exclusive face-to-face seminar which aims to give you invaluable insights and strategies to effectively navigate and thrive in the two largest healthcare markets in the world. Who is this seminar for? Companies across the life science sector with innovative products and existing or potential ambitions to grow their business internationally, specifically in the US and/or China. This includes: • Advanced medical devices and technologies. • Digital health solutions. • Biotech. • Pharmaceuticals. Join this seminar to: • Discover the market opportunities for your business. • Get tips for navigating the regulatory landscape in both markets. • Explore new partnership opportunities within each market. The seminar is free-of-charge to attend but subject to confirmation from the event organisers due to limited capacity. Registration Link: https://lnkd.in/e54HedBz #seminar #lifescience #china #US

What do a #globalpublichealth researcher with a focus on #implementationscience and #digitalhealth tools for implementation, and a #pharmacist with a focus on #nanotechnology, drug discovery and drug delivery have in common? Perhaps, not much. At first glance. But these were the hard questions and stimulating discussions the National Academy of Sciences US-Africa Frontiers in #STEM team forced us to ponder at the meeting of 96 lucky international selectees from the US and Africa, which took place in #Morocco, January 2024. Thanks to NASEM and other #transdisciplinary opportunities/ #funders like this that inspire unique #innovation and #collaboration by bringing together/ encouraging truly diverse #science, #scientists and thinkers. As a result of meeting in January, in a follow up competitive “fellow exchange” #grant from the program at NASEM, Professor Calvin Andeve Omolo and I were able to put our thinking caps on with invaluable protected time in both #Kenya (United States International University - Africa) and the US (Stanford University) with our first paper submitted ✅, two drafts along the way ✅, one grant draft ✅, and more ideas than we can count. With sincere thanks to labs that made time/ opened their doors at Stanford that further enriched Prof Omolo’s experience. In sum, truly* “supra-disciplinary” thinking is, will, can (and I argue should) be the way forward for #globalhealth. Big problems, but novel solutions await. Thank you NASEM! (PS: if you’re wondering if most of our coworking in the #BayArea occurred over - or was closely followed by - food, then… your hypothesis is likely to not be too far from wrong) Stanford University School of Medicine Stanford Center for Innovation in Global Health Stanford University Department of Emergency Medicine Bay Area Global Health Alliance #globalhealth #publichealth #medicine #science #global #international #equity #Kenya #Africa

Date for your diary - 16/10/2024 9.30am - 2.30pm The pandemic threw the life sciences industry into the spotlight, with the UK emerging as a life sciences superpower. In fact, UK life science exports were worth £24.2 billion in 2021. From aging populations to aging equipment and infrastructure, global markets are calling out for innovative technologies to solve their challenges. No more so than the two largest life sciences markets – the US and China. Between them, they accounted for almost $500 billion worth of medical imports in 2022. And your business could be the answer. But how can you break into these high growth markets? Join Santander UK and their eco-system of international providers for an exclusive face-to-face seminar which aims to give you invaluable insights and strategies to effectively navigate and thrive in the two largest healthcare markets in the world. Who is this seminar for? Companies across the life science sector with innovative products and existing or potential ambitions to grow their business internationally, specifically in the US and/or China. This includes: • Advanced medical devices and technologies. • Digital health solutions. • Biotech. • Pharmaceuticals. Join this seminar to: • Discover the market opportunities for your business. • Get tips for navigating the regulatory landscape in both markets. • Explore new partnership opportunities within each market. The seminar is free-of-charge to attend but subject to confirmation from the event organisers due to limited capacity. Registration Link: https://lnkd.in/e54HedBz #seminar #lifescience #china #US